CRP and COVID-19: In the study by Avdeev et al., netakimab was also shown to ameliorate inflammation (decrease in blood CRP levels) and blood oxygenation in patients with severe COVID-19 despite no effects on the requirement of mechanical ventilation or mortality rate.40